Ayala Pharmaceuticals Inc (ADXS)
0.555
+0.02
(+4.62%)
USD |
OTCM |
May 03, 16:00
Ayala Pharmaceuticals Gross Profit (Quarterly): 0.00 for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.09M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.003M |
| September 30, 2019 | 0.36M |
| June 30, 2019 | 0.692M |
| March 31, 2019 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.003M
Minimum
Dec 2019
0.692M
Maximum
Jun 2019
0.0633M
Average
--
Median
Mar 2020
Gross Profit (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.815M |
| Palatin Technologies Inc | 1.936M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |